Envoy Medical, Inc.
COCH- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001840877
No open-market purchases or sales by Envoy Medical, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $13.9M in total; no superinvestor holds it.
Other share classesCOCHW
13F holders, Q1 2025
Institutional positions in Envoy Medical, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −1 vs. Q4 2024
- Shares held
- 2.30M
- +333.8K (+16.9%) vs. Q4 2024
- Total value
- $3.00M
- +$117.7K (+4.1%) vs. Q4 2024
- New holders
- 1
- 6 more added
- Sold out
- 2
- 4 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting COCH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $13.9M |
| Q1 2026 | 33 | $11.5M |
| Q4 2025 | 27 | $983.0K |
| Q3 2025 | 28 | $1.65M |
| Q2 2025 | 22 | $3.28M |
| Q1 2025 | 22 | $3.00M |
| Q4 2024 | 24 | $2.95M |
| Q3 2024 | 18 | $3.33M |
| Q2 2024 | 20 | $2.74M |
| Q1 2024 | 17 | $4.59M |
| Q4 2023 | 9 | $3.01M |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Envoy Medical, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Atlas Merchant Capital LLC | 555,527 | $722.2K | 1.81% | 00.0% | Unchanged |
| Vanguard Group Inc | 394,961 | $513.4K | 0.00% | 00.0% | Unchanged |
| Weiss Asset Management LP | 387,968 | $504.4K | 0.01% | −8,686−2.2% | Reduced |
| Colony Group, LLC | 212,655 | $276.5K | 0.00% | +115,685+119.3% | Added |
| Arcus Capital Partners, LLC | 187,573 | $243.8K | 0.10% | +187,573 | New |
| DSG Capital Advisors, LLC | 163,642 | $212.7K | 0.04% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 94,232 | $122.5K | 0.00% | +6,511+7.4% | Added |
| CIBC Private Wealth Group, LLC | 77,887 | $101.3K | 0.00% | +34,705+80.4% | Added |
| Morgan Stanley | 51,541 | $67.0K | 0.00% | +10,000+24.1% | Added |
| HighPoint Advisor Group LLC | 38,662 | $54.1K | 0.00% | 00.0% | Unchanged |
| CI Private Wealth, LLC | 38,162 | $49.6K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 26,557 | $34.5K | 0.00% | +17,272+186.0% | Added |
| State Street Corp | 23,872 | $31.0K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 15,571 | $20.2K | 0.00% | −282−1.8% | Reduced |
| Northern Trust Corp | 14,043 | $18.3K | 0.00% | 00.0% | Unchanged |
| BlueStem Wealth Partners, LLC | 10,454 | $13.6K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,567 | $4.64K | 0.00% | −682−16.1% | Reduced |
| Safe Harbor Fiduciary, LLC | 2,500 | $3.25K | 0.00% | 00.0% | Unchanged |
| American Capital Advisory, LLC | 2,000 | $2.60K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1,938 | $2.52K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 66 | $86 | 0.00% | +6+10.0% | Added |
| JPMorgan Chase & Co | 19 | $25 | 0.00% | −2−9.5% | Reduced |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −28,314−100.0% | Sold out |
| SBI Securities Co., Ltd. | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Lake Street Advisors Group, LLC | – | – | – | – | Not filed |